Optimization of immunomagnetic separation for cord blood-derived hematopoietic stem cells

被引:43
作者
Kekarainen, Tuija
Mannelin, Sirkka
Laine, Jarmo
Jaatinen, Taina [1 ]
机构
[1] Finnish Red Cross Blood Serv, Helsinki, Finland
[2] Univ Autonoma Barcelona, CReSA, Barcelona, Spain
关键词
D O I
10.1186/1471-2121-7-30
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background: There is a growing interest in cord blood as a source of primitive stem cells with the capacity for multilineage differentiation. Pure cell fractions are needed for the characterization and in vitro expansion of stem cells as well as for their use in preclinical research. However, enrichment of stem cells is challenging due to the lack of stem cell-specific markers and gentle protocols for the isolation of highly pure stem cell fractions. Protocols developed for the enrichment of peripheral blood-derived stem cells have been found to be suboptimal for cord blood. Results: In this study, immunomagnetic cell sorting protocols to purify CD34+, CD133+ and Lin-cells from fresh and cryopreserved cord blood were optimized. Reproducible purities of up to 97% were reached. The selected cells were highly viable having substantial colony-forming potential. Conclusion: The optimized protocols enable rapid enrichment of highly pure hematopoietic stem cells from both fresh and cryopreserved cord blood.
引用
收藏
页数:10
相关论文
共 25 条
[1]   Clonogenic capacity and ex vivo expansion potential of umbilical cord blood progenitor cells are not impaired by cryopreservation [J].
Almici, C ;
CarloStella, C ;
Wagner, JE ;
Mangoni, L ;
Garau, D ;
Re, A ;
Giachetti, R ;
Cesana, C ;
Rizzoli, V .
BONE MARROW TRANSPLANTATION, 1997, 19 (11) :1079-1084
[2]   Associations among nucleated cell, CD34+ cell and colony-forming cell contents in cord blood units obtained through a standardized banking process [J].
Aroviita, P ;
Teramo, K ;
Westman, P ;
Hiilesmaa, V ;
Kekomäki, R .
VOX SANGUINIS, 2003, 84 (03) :219-227
[3]   Cord blood hematopoietic progenitor cell concentration and infant sex [J].
Aroviita, P ;
Teramo, K ;
Hiilesmaa, V ;
Kekomäki, R .
TRANSFUSION, 2005, 45 (04) :613-621
[4]  
Belvedere O, 1999, BLOOD CELL MOL DIS, V25, P140
[5]   Single centre experience of umbilical cord stem cell transplantation for primary immunodeficiency [J].
Bhattacharya, A ;
Slatter, MA ;
Chapman, CE ;
Barge, D ;
Jackson, A ;
Flood, TJ ;
Abinun, M ;
Cant, AJ ;
Gennery, AR .
BONE MARROW TRANSPLANTATION, 2005, 36 (04) :295-299
[6]   GROWTH-CHARACTERISTICS AND EXPANSION OF HUMAN UMBILICAL-CORD BLOOD AND ESTIMATION OF ITS POTENTIAL FOR TRANSPLANTATION IN ADULTS [J].
BROXMEYER, HE ;
HANGOC, G ;
COOPER, S ;
RIBEIRO, RC ;
GRAVES, V ;
YODER, M ;
WAGNER, J ;
VADHANRAJ, S ;
BENNINGER, L ;
RUBINSTEIN, P ;
BROUN, ER .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (09) :4109-4113
[7]   HUMAN UMBILICAL-CORD BLOOD AS A POTENTIAL SOURCE OF TRANSPLANTABLE HEMATOPOIETIC STEM PROGENITOR CELLS [J].
BROXMEYER, HE ;
DOUGLAS, GW ;
HANGOC, G ;
COOPER, S ;
BARD, J ;
ENGLISH, D ;
ARNY, M ;
THOMAS, L ;
BOYSE, EA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (10) :3828-3832
[8]   Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood? [J].
Grewal, SS ;
Barker, JN ;
Davies, SM ;
Wagner, JE .
BLOOD, 2003, 101 (11) :4233-4244
[9]   A FUNCTIONAL COMPARISON OF CD34(+)CD38(-) CELLS IN CORD-BLOOD AND BONE-MARROW [J].
HAO, QL ;
SHAH, AJ ;
THIEMANN, FT ;
SMOGORZEWSKA, EM ;
CROOKS, GM .
BLOOD, 1995, 86 (10) :3745-3753
[10]  
Hogan CJ, 1997, BLOOD, V90, P85